Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVTR Avantor	$13.88 -0.1%	$13.13	$11.82 ▼ $28.00	$9.46B	1.05	8.39 million shs	6.23 million shs
DHR Danaher	$203.08 +0.3%	$195.63	$171.00 ▼ $281.70	$145.33B	0.77	3.49 million shs	1.39 million shs
IQV IQVIA	$164.24 -0.2%	$150.86	$134.65 ▼ $252.88	$28.41B	1.3	1.65 million shs	674,106 shs
TMO Thermo Fisher Scientific	$428.25 +0.1%	$409.18	$385.46 ▼ $627.88	$161.66B	0.77	1.97 million shs	1.36 million shs

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVTR Avantor	0.00%	+2.47%	+6.16%	-8.98%	-34.00%
DHR Danaher	0.00%	+2.46%	+3.54%	+12.38%	-15.12%
IQV IQVIA	0.00%	+4.26%	+8.00%	+7.55%	-21.08%
TMO Thermo Fisher Scientific	0.00%	+5.05%	+6.53%	-2.18%	-20.71%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVTR Avantor	4.9839 of 5 stars	4.2	5.0	0.0	3.2	3.7	3.3	2.5
DHR Danaher	4.8617 of 5 stars	3.4	3.0	1.7	4.3	3.6	3.3	1.3
IQV IQVIA	4.9162 of 5 stars	4.4	2.0	0.0	4.6	3.2	1.7	2.5
TMO Thermo Fisher Scientific	4.9931 of 5 stars	4.4	3.0	2.5	4.1	3.5	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVTR Avantor	2.42	Hold	$18.14	30.67% Upside
DHR Danaher	2.80	Moderate Buy	$248.61	22.42% Upside
IQV IQVIA	2.75	Moderate Buy	$226.32	37.80% Upside
TMO Thermo Fisher Scientific	2.80	Moderate Buy	$604.05	41.05% Upside

Current Analyst Ratings Breakdown

Latest AVTR, DHR, IQV, and TMO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/24/2025	DHR Danaher	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$215.00 ➝ $225.00
6/24/2025	TMO Thermo Fisher Scientific	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$475.00 ➝ $450.00
6/5/2025	DHR Danaher	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		$240.00 ➝ $235.00
5/23/2025	IQV IQVIA	Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$188.00
5/22/2025	IQV IQVIA	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
5/19/2025	IQV IQVIA	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$232.00 ➝ $177.00
5/15/2025	IQV IQVIA	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$210.00 ➝ $190.00
5/7/2025	IQV IQVIA	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$195.00 ➝ $161.00
5/7/2025	IQV IQVIA	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$255.00 ➝ $185.00
5/7/2025	IQV IQVIA	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$170.00 ➝ $165.00
4/29/2025	AVTR Avantor	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight

(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVTR Avantor	$6.78B	1.39	$1.61 per share	8.63	$8.75 per share	1.59
DHR Danaher	$23.88B	6.09	$10.92 per share	18.60	$68.60 per share	2.96
IQV IQVIA	$15.41B	1.84	$16.61 per share	9.89	$33.43 per share	4.91
TMO Thermo Fisher Scientific	$42.88B	3.77	$29.95 per share	14.30	$129.54 per share	3.31

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVTR Avantor	$711.50M	$1.04	13.35	11.57	1.47	10.70%	11.93%	5.50%	7/25/2025 (Estimated)
DHR Danaher	$3.90B	$5.15	39.43	23.70	2.85	15.81%	10.80%	6.89%	7/22/2025 (Estimated)
IQV IQVIA	$1.37B	$7.34	22.38	13.46	1.82	8.61%	29.16%	6.96%	7/22/2025 (Estimated)
TMO Thermo Fisher Scientific	$6.34B	$17.05	25.12	16.75	2.28	15.19%	17.15%	8.47%	7/23/2025 (Estimated)

Latest AVTR, DHR, IQV, and TMO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/25/2025	Q2 2025	AVTR Avantor	$0.25	N/A	N/A	N/A	$1.67 billion	N/A
7/23/2025	Q2 2025	TMO Thermo Fisher Scientific	$5.22	N/A	N/A	N/A	$10.68 billion	N/A
7/22/2025	Q2 2025	DHR Danaher	$1.64	N/A	N/A	N/A	$5.83 billion	N/A
7/22/2025	Q2 2025	IQV IQVIA	$2.76	N/A	N/A	N/A	$3.96 billion	N/A
5/6/2025	Q1 2025	IQV IQVIA	$2.63	$2.70	+$0.07	$1.40	$3.77 billion	$3.83 billion
4/25/2025	Q1 2025	AVTR Avantor	$0.23	$0.23	N/A	$0.09	$1.61 billion	$1.58 billion
4/23/2025	Q1 2025	TMO Thermo Fisher Scientific	$5.10	$5.15	+$0.05	$3.98	$10.23 billion	$10.36 billion
4/22/2025	Q1 2025	DHR Danaher	$1.62	$1.88	+$0.26	$1.32	$5.58 billion	$5.74 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVTR Avantor	N/A	N/A	N/A	N/A	N/A
DHR Danaher	$1.28	0.63%	N/A	24.85%	2 Years
IQV IQVIA	N/A	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	$1.72	0.40%	N/A	10.09%	8 Years

Latest AVTR, DHR, IQV, and TMO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/6/2025	DHR Danaher	quarterly	$0.32	0.67%		6/27/2025	7/25/2025
5/21/2025	TMO Thermo Fisher Scientific	quarterly	$0.43	0.43%	6/13/2025	6/13/2025	7/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVTR Avantor	0.54	1.12	0.75
DHR Danaher	0.31	1.43	1.05
IQV IQVIA	2.19	0.82	0.82
TMO Thermo Fisher Scientific	0.64	1.77	1.38

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVTR Avantor	95.08%
DHR Danaher	79.05%
IQV IQVIA	89.62%
TMO Thermo Fisher Scientific	89.23%

Insider Ownership

Company	Insider Ownership
AVTR Avantor	1.20%
DHR Danaher	11.20%
IQV IQVIA	1.60%
TMO Thermo Fisher Scientific	0.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVTR Avantor	13,500	681.43 million	673.25 million	Optionable
DHR Danaher	63,000	715.67 million	635.52 million	Optionable
IQV IQVIA	88,000	173.00 million	170.23 million	Optionable
TMO Thermo Fisher Scientific	125,000	377.49 million	376.25 million	Optionable

AVTR, DHR, IQV, and TMO Headlines

Recent News About These Companies

Thermo Fisher Scientific: Recovery In Sight, Attractively Valued

4 hours ago | seekingalpha.com

Thermo Fisher Scientific: Recovery In Sight, Attractively Valued

4 hours ago | seekingalpha.com

Chilton Capital Management LLC Raises Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 6 at 9:17 AM | marketbeat.com

Financiere des Professionnels Fonds d investissement inc. Trims Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 6 at 9:05 AM | marketbeat.com

Vickerman Investment Advisors Inc. Makes New $393,000 Investment in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 6 at 7:26 AM | marketbeat.com

Truist Financial Corp Sells 6,419 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

July 6 at 6:31 AM | marketbeat.com

Brookstone Capital Management Has $4.05 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 6 at 6:14 AM | marketbeat.com

Wells Fargo maintained a Buy rating on Thermo Fisher Scientific (TMO)

July 6 at 3:46 AM | msn.com

FDA Approved Thermo Fisher Scientific’s (TMO) Oncomine Dx Express Test

July 6 at 3:46 AM | msn.com

Thermo Fisher Scientific’s NGS assay, Oncomine Dx Express Test receives US FDA approval as a companion diagnostic for Dizal’s Zegfrovy

July 5 at 12:39 PM | pharmabiz.comP

Thermo Fisher Scientific (NYSE:TMO) Gains FDA Approval for Rapid Cancer Diagnostic Tool

July 5 at 12:39 PM | finance.yahoo.com

Novare Capital Management LLC Decreases Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 5 at 9:00 AM | marketbeat.com

Adell Harriman & Carpenter Inc. Increases Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 5 at 8:50 AM | marketbeat.com

Braun Stacey Associates Inc. Trims Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 5 at 8:41 AM | marketbeat.com

HM Payson & Co. Buys 8,904 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

July 5 at 8:32 AM | marketbeat.com

Bank of New York Mellon Corp Cuts Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 5 at 8:25 AM | marketbeat.com

VELA Investment Management LLC Makes New $1.17 Million Investment in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 5 at 8:09 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Impax Asset Management Group plc

July 5 at 6:53 AM | marketbeat.com

Harel Insurance Investments & Financial Services Ltd. Acquires Shares of 1,045 Thermo Fisher Scientific Inc. (NYSE:TMO)

July 5 at 6:29 AM | marketbeat.com

OneDigital Investment Advisors LLC Has $7.19 Million Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 5 at 6:27 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Stock Holdings Lowered by Kintegral Advisory LLC

July 4 at 8:38 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVTR, DHR, IQV, and TMO Company Descriptions

Avantor NYSE:AVTR

$13.88 -0.01 (-0.07%)

Closing price 07/3/2025 03:30 PM Eastern

Extended Trading

$13.82 -0.06 (-0.44%)

As of 05:06 AM Eastern

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Danaher NYSE:DHR

$203.08 +0.58 (+0.28%)

Closing price 07/3/2025 03:43 PM Eastern

Extended Trading

$202.00 -1.07 (-0.53%)

As of 05:17 AM Eastern

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

IQVIA NYSE:IQV

$164.24 -0.41 (-0.25%)

Closing price 07/3/2025 03:30 PM Eastern

Extended Trading

$165.27 +1.03 (+0.63%)

As of 04:01 AM Eastern

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

Thermo Fisher Scientific NYSE:TMO

$428.25 +0.49 (+0.11%)

Closing price 07/3/2025 03:58 PM Eastern

Extended Trading

$428.72 +0.46 (+0.11%)

As of 05:21 AM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time